The effect of pyruvate or dihydroxyacetone on parenterally induced liver lipid accumulation in the rat.
Orally fed pyruvate (pyr) and dihydroxyacetone (DHA) have been shown to decrease liver lipid accumulation in animal models. These compounds lessen the degree of fatty liver in ethanol-fed rats and in a genetic strain of hens predisposed to fatty liver. Total parenteral nutrition can result in liver dysfunction, including fatty infiltration of the liver. In this study, rats were assigned to either control, pyr, or DHA groups. All rats were fitted with jugular vein catheters, and following a 3-day recovery, were infused continuously for 7 days. The infusate provided adequate nutrition (including 7% kcal as fat) with 5% pyr or 5% DHA (g/liter) substituted for dextrose in the experimental groups. Plasma triglycerides were lower in the pyr groups relative to controls: 62.2 +/- 34.7 (SE) vs 96.8 +/- 44.3 mg/dl, though this was significant only at P less than 0.10. Neither pyr nor DHA decreased liver lipids. Pyr and DHA were administered intravenously in this study, and therefore passed through the heart and to peripheral tissues first. These compounds may need to be fed orally, passing via the portal system, to produce the liver lipid-lowering effects seen in other studies.
Olson
B H
BH
Department of Nutrition, School of Veterinary Medicine, University of California, Davis 95616.
Schneeman
B O
BO
Freedland
R A
RA
D000818:Animals; D004098:Dihydroxyacetone / Q000494:pharmacology*; D007262:Infusions, Intravenous; D008055:Lipids / Q000032:analysis* / Q000097:blood; D008099:Liver / Q000737:chemistry / Q000187:drug effects*; D008112:Liver Glycogen / Q000032:analysis; D008297:Male; D011773:Pyruvates / Q000494:pharmacology*; D019289:Pyruvic Acid; D051381:Rats; D011919:Rats, Inbred Strains; D014280:Triglycerides / Q000097:blood; D015430:Weight Gain / Q000187:drug effects
D008055:Lipids; D008112:Liver Glycogen; D011773:Pyruvates; D014280:Triglycerides; D019289:Pyruvic Acid; D004098:Dihydroxyacetone